tiprankstipranks
Trending News
More News >
Almado, Inc. (JP:4932)
:4932
Japanese Market
Advertisement

Almado, Inc. (4932) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4932

Almado, Inc.

(4932)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
¥1,208.00
▲(9.03% Upside)
Almado, Inc. has a solid financial foundation with strong revenue growth and stable margins, but increased leverage and negative cash flow are concerns. Technical indicators suggest a lack of strong momentum, and the stock is fairly valued with an attractive dividend yield. Attention to cash flow management is crucial for future performance.

Almado, Inc. (4932) vs. iShares MSCI Japan ETF (EWJ)

Almado, Inc. Business Overview & Revenue Model

Company DescriptionAlmado, Inc. engages in the planning, development, and sale of cosmetics and supplements in Japan. The company offers basic cosmetics, makeup cosmetics, supplements, and quasi-drugs under the TO-II, Ode, CELLULA, Type III, AMF, Almado La Dina, and other brands. It also operates online stores for its products. The company was incorporated in 2000 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyAlmado, Inc. generates revenue through multiple streams, primarily through subscription fees for its software products and services. The company offers a tiered subscription model that allows businesses to select plans based on their size and specific needs, ensuring a steady and predictable revenue flow. Additionally, Almado earns income from professional services, including consulting, implementation, and ongoing support for clients using its solutions. Strategic partnerships with other technology firms and cloud service providers further enhance its offerings, allowing Almado to bundle services and cross-sell products, thus increasing its market reach and revenue potential. The company also engages in licensing agreements, providing its technology to third parties, which contributes to its earnings significantly.

Almado, Inc. Financial Statement Overview

Summary
Almado, Inc. shows strong revenue growth and stable margins, but increased leverage and recent negative cash flow are concerns. The company has a solid equity position, indicating resilience and growth potential, but needs to address cash flow management.
Income Statement
Almado, Inc. has demonstrated strong revenue growth over the past years, with a notable increase from 2024 to 2025. The gross profit margin remains robust, indicating effective cost management. However, the net profit margin has slightly decreased, suggesting increased expenses or other cost pressures. EBIT and EBITDA margins are stable, reflecting consistent operational efficiency.
Balance Sheet
The company's debt-to-equity ratio has increased, indicating higher leverage, which could pose a risk if not managed properly. However, the equity ratio remains healthy, and return on equity is strong, suggesting effective use of shareholder funds. The increase in total assets and equity over time reflects a solid financial position.
Cash Flow
Almado, Inc. experienced a significant decline in free cash flow in 2025, primarily due to negative operating cash flow. This raises concerns about cash generation capabilities. However, the company has previously shown strong free cash flow growth, and the operating cash flow to net income ratio indicates potential for recovery if operational challenges are addressed.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue9.24B8.48B7.54B6.53B5.37B4.55B
Gross Profit6.51B5.89B5.07B4.35B3.32B2.80B
EBITDA699.11M982.63M983.22M855.74M853.59M558.82M
Net Income460.97M650.41M695.46M585.80M582.21M367.96M
Balance Sheet
Total Assets4.83B4.72B3.83B3.67B3.36B2.98B
Cash, Cash Equivalents and Short-Term Investments1.18B1.57B1.51B1.39B1.18B1.13B
Total Debt3.31B2.11B1.00B551.89M72.79M73.66M
Total Liabilities4.16B2.85B1.95B1.34B675.56M667.67M
Stockholders Equity669.08M1.87B1.88B2.33B2.69B2.32B
Cash Flow
Free Cash Flow0.00-243.98M834.63M704.62M250.50M640.85M
Operating Cash Flow0.00-189.09M846.27M711.75M260.42M653.96M
Investing Cash Flow0.00-108.06M-1.58M-7.13M-9.72M-13.11M
Financing Cash Flow0.00354.84M-720.19M-492.02M-208.23M-50.84M

Almado, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1108.00
Price Trends
50DMA
1137.98
Negative
100DMA
1115.20
Negative
200DMA
1100.71
Positive
Market Momentum
MACD
-12.22
Negative
RSI
49.01
Neutral
STOCH
89.62
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4932, the sentiment is Positive. The current price of 1108 is above the 20-day moving average (MA) of 1101.35, below the 50-day MA of 1137.98, and above the 200-day MA of 1100.71, indicating a neutral trend. The MACD of -12.22 indicates Negative momentum. The RSI at 49.01 is Neutral, neither overbought nor oversold. The STOCH value of 89.62 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4932.

Almado, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
¥10.95B21.675.87%27.84%51.43%
67
Neutral
¥10.80B29.522.20%10.56%-52.16%
63
Neutral
¥6.30B9.842.40%-3.27%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
52
Neutral
¥6.31B13.37-20.62%
49
Neutral
¥11.23B0.47%9.74%-669.35%
45
Neutral
¥5.12B20.351.67%7.21%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4932
Almado, Inc.
1,108.00
170.29
18.16%
JP:4925
HABA Laboratories, Inc.
1,664.00
-204.81
-10.96%
JP:4926
C'BON COSMETICS Co., Ltd.
1,199.00
-31.32
-2.55%
JP:4934
Premier Anti-Aging Co., Ltd.
722.00
3.00
0.42%
JP:4935
Liberta Co., Ltd.
1,947.00
1,308.62
204.99%
JP:4936
AXXZIA, Inc.
454.00
-79.25
-14.86%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025